Gland Pharma Q3 Results

  • BSE: 543245
  • NSE: GLAND
  • ISIN: INE068V01023
  • Sector: Biotechnology & Drugs
BSE
1,78528.45 (1.62%)
Volume4.99 K
Updated: Mon 25 Nov, 2024 | 15:29:46
NSE
1,773.9518.90 (1.08%)
Volume1.73 L
Updated: Mon 25 Nov, 2024 | 15:40:43
Today: 1,755.70
1,793.75
52-Wk: 1,590.00
2,220.95

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Gland Pharma Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 1,545.151,373.42-%938.29-%
    Selling/ General/ Admin Expenses Total 409.37363.23-%130.35-%
    Depreciation/ Amortization 105.3481.30-%37.61-%
    Other Operating Expenses Total 180.16164.55-%91.30-%
    Total Operating Expense 1,294.111,130.64-%686.33-%
    Operating Income 251.05242.78-%251.96-%
    Net Income Before Taxes 283.16289.89-%310.85-%
    Net Income 191.86194.08-%231.95-%
    Diluted Normalized EPS 11.6511.78-%14.08-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts